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School-aged children after the end of successful treatment of non-central nervous system cancer: longitudinal
assessment of health-related quality of life, anxiety and coping
The aim of the study was to investigate: (1) health-related quality of life (HRQoL) and anxiety in school-aged
cancer survivors during the first 4 years of continuous remission after the end of treatment; and (2) correlations
of disease-related coping with HRQoL and anxiety. A total of 76 survivors aged 8–15 years completed
questionnaires about HRQoL, anxiety and disease-related cognitive coping at one to five measurement occa-
sions. Their HRQoL was compared with norm data, 2 months (n = 49) and 1 year (n = 41), 2 years (n = 41), 3
years (n = 42) and 4 years (n = 27) after treatment. Through longitudinal mixed models analyses it was
investigated to what extent disease-related cognitive coping was associated with HRQoL and anxiety over
time, independent of the impact of demographic and medical variables. Survivors reported worse Motor
Functioning (HRQoL) 2 months after the end of treatment, but from 1 year after treatment they did no longer
differ from the norm population. Lower levels of anxiety were associated with male gender, being more
optimistic about the further course of the disease (predictive control) and less searching for information about
the disease (interpretative control). Stronger reliance on the physician (vicarious control) was associated with
better mental HRQoL. As a group, survivors regained good HRQoL from 1 year after treatment. Monitoring and
screening survivors are necessary to be able to trace the survivors at risk of worse HRQoL.
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INTRODUCTION
The treatment of patients with childhood cancer has enor-
mously improved in recent decades. Many patients who
may previously have had a limited life expectancy are now
growing up with childhood cancer and surviving into
adulthood. The overall 5-year survival rate for children
diagnosed with cancer in Europe is currently more than
70% compared with 30% in the 1960s (Stiller et al. 2005;
Magnani et al. 2006).
The diagnosis and treatment of childhood cancer is a
dramatic event that affects the daily life and emotional
well-being of all family members (Eiser 2004). An
increasing number of studies have been directed at
assessing health-related quality of life (HRQoL) and emo-
tional adjustment in long-term survivors of childhood
cancer. Less is known about the first few years after
treatment in the run-up to long-term survivorship, and
longitudinal studies are sparse. Sawyer et al. (2000) found
that patients had behavioural–emotional problems imme-
diately after diagnosis, but in the next 4 years the scores
were generally consistent with those in the control
group. Others (Kazak et al. 1994; Radcliffe et al. 1996;
Grootenhuis & Last 2001) reported that survivors did not
show elevated levels of anxiety in comparison with the
norm in the first years after termination of treatment.
Recently, we found that 2 months after the end of suc-
cessful cancer treatment, paediatric patients and their
parents experienced worse HRQoL than the general popu-
lation did, to a clinically relevant extent (Stam et al.
2006).
Demographic and medical factors related to the
HRQoL and emotional functioning of paediatric survi-
vors have been discussed to some extent in many studies.
The results, however, were not consistent, and most
study designs were cross-sectional so that causality can
not be established. What can be concluded is that older
age at diagnosis, longer time off treatment, irradiation
therapy and severe medical late effects were associated
with worse psychosocial functioning in paediatric long-
term survivors of childhood cancer [see review of Stam
et al. (2001)].
The role of coping is important in relation to the
adjustment to childhood cancer (Last & Grootenhuis
1998). Coping consists of actions, behaviours and
thoughts aimed at dealing with the demands of events
and situations that are appraised as stressful (Lazarus &
Folkman 1984). So, coping mediates the effect of a stres-
sor on an individual’s well-being. In the context of coping
with a life-threatening illness the following disease-
related cognitive control strategies were found to be rel-
evant (Grootenhuis et al. 1996). Predictive control means
that patients attempt to predict events in order to create
the feeling that they are able to control the situation.
Having positive expectations helps patients to deal with
the consequences of disease. Vicarious control strategies
concern the attribution of special power to others in the
case of cancer patients to the doctors, on whom they are
dependent, and all hope is focused. Because one can not
alter the course of the disease, belief in powerful others
can be adaptive. Interpretative control refers to the
search for meaning and understanding. Using informa-
tion to help to understand emotional reactions or to
reduce uncertainty is interpretative control strategies.
Finally, with illusory control one attempts to associate
with chance, such as hoping for a miracle or wishful
thinking.
Some studies on coping strategies in paediatric survi-
vors of cancer were found. Madan-Swain et al. (1994)
found that, overall, survivors used coping strategies
which were comparable with the strategies used by con-
trols. Others found that survivors tended to apply more
avoidance strategies in stressful situations than a
healthy control group (Bauld et al. 1998), which is in line
with the coping strategies found in paediatric cancer
patients during treatment (Phipps et al. 2001; Landolt
et al. 2002). It is difficult, however, to conclude whether
coping is associated with the patient’s functioning
because most studies have been focused on coping as
an outcome variable, rather than a predictor. Moreover,
the few studies on the impact of coping on survivors’
functioning showed inconsistent results (Phipps et al.
2001).
The more we understand about disease-related coping
and about the relation of coping with survivors’ function-
ing, the better healthcare providers will be able to help
patients to live with the consequences of their disease.
The present study was therefore directed at HRQoL and
emotional functioning as well as disease-related coping. A
longitudinal study was designed among 76 school-aged
survivors with the following research questions: (1) How
are the course of HRQoL and anxiety of survivors during
the first 4 years of continuous remission following the
completion of treatment for cancer? and (2) To what
extent is disease-related cognitive coping associated with
survivors’ HRQoL and anxiety during the first 4 years of
continuous remission following the completion of treat-
ment for cancer? Although a 5-year period without treat-
ment is commonly considered a criterion of survival, we
decided to call the patients in our study ‘survivors’
because they were in continuous remission in the run-up
to long-term survivorship.
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MATERIAL AND METHODS
Procedure
The results presented here are taken from a Dutch study
on the late psychosocial consequences of cancer in child-
hood, which started in 2000 and ended in 2006, the
Vragenlijsten KinderOncologie Latere Gevolgen (VOLG;
Questionnaire on childhood cancer late questionnaire)
study. From 2000 to 2002, survivors and their parents
were recruited from two Dutch university hospitals, the
Emma Children’s Hospital at the Academic Medical
Center in Amsterdam and the Radboud University
Nijmegen Medical Center. The Medical Ethics Commit-
tees of the hospitals have approved the study protocol.
All consecutive survivors who met the inclusion crite-
ria during these periods were invited to participate in the
VOLG study. The inclusion criteria were: (1) age 1–18
years; (2) complete remission; (3) end of successful treat-
ment at most 2 months before; and (4) ability to complete
Dutch questionnaires. The self-reported data of survivors
aged 8–15 years (‘school-aged survivors’) were used in the
present study. This means that the data were included in
the analyses at the measurement occasions that the
respondent was aged 8–15 years.
Once informed consent had been obtained from both the
survivors and their parents, the respondents completed
several questionnaires, 4–6 times, depending on the year of
inclusion. The first five assessments were used for analy-
ses: approximately 2 months (M1), 1 year (M2), 2 years
(M3), 3 years (M4) and 4 years (M5) after the end of treat-
ment. Data of the sixth measurement occasion and data for
survivors with central nervous system (CNS) tumours
were not used because of too small numbers of respon-
dents. Furthermore, the data for patients who relapsed were
excluded from analysis from the moment of the relapse.
MEASURES
Dependent variables: HRQoL and anxiety
The TNO-AZL Children’s Quality of Life Questionnaire
(TACQOL) for children aged 8–15 years (Verrips et al. 1999;
Vogels et al. 2004a,b) was used. This is a generic Dutch
instrument that measures HRQoL on group level in a
reliable and valid way. Norm data from the general Dutch
population are available (Verrips et al. 1998, 1999; Vogels
et al. 1998). The questionnaire measures health status
problems weighed by the impact of the problems on well-
being. Most of the items consist of two questions linked to
one another. The first one is about the frequency of the
problem in the past few weeks. The second one rates the
possible negative emotional responses to the problems on a
4-point Likert scale. The items are clustered into seven
multi-item scales with higher scores indicating better
HRQoL: Physical Complaints, Motor Functioning,
Autonomy, Cognitive Functioning, Social Functioning,
Positive Emotions and Negative Emotions. Following the
method of Ware & Kosinski (2001) we used Principal Com-
ponent Analysis (PCA) to aggregate all TACQOL scale
scores into two summary scales: the Mental Component
Scale (MCS) and the Physical Component Scale (PCS). The
relative contribution of each scale to MCS and PCS was
derived from PCA at M1, oblique rotation (Oblimin).
Anxiety was measured with the Dutch version of the
State-Trait Inventory for Children, the ZBV-K (Bakker
et al. 1989). The ‘trait’ version was used to assess the
tendency to respond with anxiety in a stressful situation.
This version is more appropriate to measure the overall
level of anxiety a child experiences than the ‘state’ version
that measures conditional anxiety at the very moment of
assessment. Higher scores indicate higher levels of
anxiety. The norm data from the general Dutch popula-
tion of school-aged children (Bakker et al. 1989) could not
be used because only gender-specific norm data were
available, which resulted into too small subgroups of sur-
vivors at the several measurement occasions.
Independent variables: disease-related cognitive control
and medical variables
Disease-related cognitive coping was assessed with the
Cognitive Control Strategies Scale (CCSS) for patients.
The instrument, based on the model of Rothbaum et al.
(1982), was developed at the Psychosocial Department of
the Emma Children’s Hospital/AMC. It assesses to what
extent respondents try to gain sense of control over the
illness by using cognitive coping strategies, measured on a
4-point Likert scale. Higher scores represent a stronger
reliance upon the control strategy. The questionnaire
proved to be reliable and useful in earlier studies (Grooten-
huis & Last 2001; Loonen et al. 2002; Stam et al. 2006).
The items of the CCSS-CF were grouped into four scales,
as described in Introduction: predictive, vicarious, inter-
pretative and illusory control. The Illusory Control Scale
was not used in analyses because of insufficient internal
consistency.
Medical data were obtained from the survivor’s medical
record. The prognosis was based on the survival chances at
diagnosis as rated by each survivor’s oncologist, namely
<25%, 25–75% or >75%. After the end of treatment (M1),
the parents were asked to rate their perception of the
intensiveness of their child’s treatment on a Visual Ana-
logue Scale, from ‘totally non-intensive’ (0, left end of line)
HRQoL, anxiety and coping school-aged cancer survivors
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to ‘very intensive’ (10, right end of line). They were also
asked to assess the visible consequences of the disease.
Their answers were dichotomized to ‘presence’ or
‘absence’ of visible consequences.
Statistical analyses
spss version 12.0 was used for all analyses. Survivors’
HRQoL over time was compared with norm data for the
general Dutch population of children aged 8–11 years and
12–15 years, with respect to the four TACQOL scales with
sufficient internal consistency at each measurement occa-
sion: Motor Functioning, Cognitive Functioning, Positive
Emotions and Negative Emotions. One sample t-tests or
non-parametric equivalents (one sample sign-test or bino-
mial test) were performed to test (at P < 0.05, two-sided)
whether the mean score, the median or the binomial dis-
tribution of the scales scores in the childhood cancer sur-
vivors differed from that in the norm population.
Linear mixed model analysis (Snijders & Bosker 2004)
was performed to examine the course of HRQoL and
anxiety, and to explore to what extent disease-related cog-
nitive coping was predictive of HRQoL (PCS and MCS) and
anxiety, while controlling for demographic and medical
variables. To account of repeated measures within respon-
dents, linear mixed models were fitted to the data. These
models can also be characterized as multi-level models for
longitudinal data, with measurement occasions as first
level units of analysis and respondents as second level
units. The major advantage of linear mixed model analysis
is that all available data are incorporated into the analysis,
including data from survivors who missed one or more
measurement occasions. Changes in the numbers of sub-
jects from occasion to occasion do not harm the analysis,
other than that the statistical power to find deviations
from baseline decreases with higher attrition.
To facilitate interpretation of regression coefficients, all
continuous scores were transformed into standard normal
scores, expressing deviations from the mean at M1. We
considered standardized regression coefficients of 0.1 as
small, 0.3 as medium and 0.5 as large after Cohen (1988).
For binary coded predictor variables, regression coeffi-
cients of 0.2 can be considered small, 0.5 medium and
0.8 large.
Measurement occasions were treated as fixed because
growth-curve models were not appropriate for these data.
The intercept was considered random with its mean equal
to the standardized mean outcome at M1, thus taking the
outcome at M1 as reference point. In this way, parameter
estimates for M2 through M5 can be interpreted as devia-
tions from baseline (M1). The deviations were treated as
fixed parameters after checking for random parameters,
using Akaike’s information criterion.
Models were fitted for PCS, MCS and anxiety. Because
of the large number of predictor variables in relation to
the sample size, pre-selection was necessary. The initial
model consisted of the random intercept (M1) and the
fixed parameters for measurement occasions M2 to
M5. Demographic and medical predictor variables were
entered one by one into the initial model. If significant at
least at 0.3, the demographic and medical variables were
selected for the final model. All three variables concerning
cognitive coping were included. The final model thus con-
sisted of the random intercept (M1), the fixed regression
coefficients for M2 through M5 and the three coping vari-
ables, completed with the demographic and medical pre-
dictor variables that remained after pre-selection. For one
outcome anxiety, there appeared to be no intercept vari-
ance. The final model for this outcome was therefore
fitted with a fixed intercept. Percentages of total explained
variance were calculated.
For each model, we checked whether the longitudinal
covariance structure was best described by compound
symmetry or by an autoregressive structure, with refer-
ence to Akaike’s information criterion. Compound
symmetry appeared to give the best fit for all models.
Furthermore, we checked whether first-order interaction
effects of measurement occasion with the other predictor
variables should be added to the model. To prevent too
many findings occurring by chance, these tests were
carried out at Bonferroni adjusted level of significance. We
concluded that it was not necessary to add any of the
first-order interaction effects.
RESULTS
Participants
A total of 164 consecutive survivors whose cancer treat-
ment had successfully ended, were invited to participate
in the longitudinal part of the VOLG study. The response
rate was 81.7% (n = 134). The 30 families who did not
participate did not differ from participating families with
respect to demographic and medical variables (P < 0.1 at
t-tests or c2-tests).
A total of 76 survivors that were included in the present
study were aged 8–15 years at one or more measurement
occasions: 49 survivors at M1, 41 at M2, 41 at M3, 42 at M4
and 27 at M5. Characteristics of survivors are presented in
Table 1. Dropout because of non-response was 2.6% (n = 2).
Furthermore, after recurrence of the childhood cancer, data
of subsequent measurement occasions were excluded from
analyses (n = 8, 10.5%). So, it depends on the moment of
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relapse how many measurement occasions were included.
Data at M5 were not available in 19 (25.0%) survivors
because of the finite follow-up period of the VOLG study.
The survivors included at M2, M3, M4 and M5 did not
differ significantly (P < 0.05) from the survivors at M1 with
respect to their demographic and medical characteristics,
except for age at diagnosis. The survivors at M1 were older
at diagnosis than the survivors at the other measurement
occasions. Furthermore, some differences were found
between survivors at M5 and those at M1, as shown in
Table 1. Finally, participants did not differ from the non-
participants at the several measurement occasions with
respect to their outcome scores at T1.
Health-related quality of life and anxiety over time
On average 2 months after the end of successful treatment
(M1), survivors aged 8–11 years scored significantly
worse on Motor Functioning (P < 0.05) than the general
Dutch population: M = 27.7 (standard deviation = 4.6) vs.
M = 29.8 (standard deviation = 3.2). At M1, also survivors
aged 12–15 years reported significantly worse Motor Func-
tioning (P < 0.001) than the general Dutch population:
M = 24.8 (standard deviation = 5.4) vs. M = 29.8 (standard
deviation = 3.3). The differences were large, d = -0.7 and
d = -1.6 respectively. One (M2), two (M3), three (M4) and
four years (M5) after the end of treatment, survivor’s level
of Motor Functioning was normalized in both aged groups.
The survivors aged neither 8–11 nor 12–15 years differed
from the general population with respect to Cognitive
Functioning, Positive Emotions and Negative Emotions at
any measurement occasion (Fig. 1a and b).
Predictors of HRQoL
Parameter estimates from the longitudinal mixed models
analyses of survivor’s HRQoL are shown in Table 2. Sur-
vivors reported significant higher scores on PCS 1–4 years
after the end of treatment than at 2 months. The effects
of time were small to medium. Principal Component
Analysis was not predicted significantly (P < 0.05) by any
demographic, medical or coping variable. Interpretative
control, however, was associated negatively with PCS at
P = 0.08 (b = -0.10).
MCS, in contrast with PCS, was not associated signifi-
cantly (P < 0.05) with measurement occasion, although at
Table 1. Characteristics of the survivors
Measurement: time since
end of treatment M1 2 months M2 1 year M3 2 years M4 3 years M5 4 years
n 49 41 41 42 27
Gender (female): n (%) 17 (34.7) 15 (36.6) 13 (31.7) 15 (35.7) 5 (18.5)
Age (range at M1: 8.1–15.9): mean (standard
deviation)
12.1 (2.3) 11.8 (2.5) 11.5 (2.5) 11.5 (2.4) 10.9 (2.2)*
Age category: n (%)
8–11 years 23 (46.9) 19 (46.3) 25 (61.0) 25 (59.5) 21 (77.8)
12–15 years 26 (53.1) 22 (53.7) 16 (39.0) 17 (40.5) 6 (22.2)
Age at diagnosis (range at M1: 6.4–15.2): mean
(standard deviation)
11.0 (2.4) 9.9 (2.5)* 8.6 (2.6)* 7.5 (2.7)* 5.7 (2.4)*
Time since diagnosis (months) (range at M1:
2.0–28.0): mean (standard deviation)
13.2 (7.2) 23.7 (7.1) 35.2 (7.9) 48.3 (8.9) 62.4 (10.4)
Duration of treatment (months) (range at M1:
1.2–25.7): mean (standard deviation)
10.9 (7.3) 10.7 (6.9) 10.9 (7.7) 12.1 (8.6) 14.3 (10.3)
Diagnosis: n (%)
Leukaemia/lymphoma
Solid tumour 24 (49.0) 18 (43.9) 20 (48.8) 22 (52.4) 20 (74.1)
Treatment: n (%) 25 (51.0) 23 (56.1) 21 (51.2) 20 (47.6) 7 (25.9)
Chemotherapy 48 (98.0) 41 (100) 41 (100) 42 (100) 27 (100)
Radiotherapy 8 (16.3) 6 (14.6) 4 (9.8) 4 (9.5) 0*
Surgery 21 (42.9) 21 (51.2) 20 (48.8) 20 (47.6) 10 (37.0)
Autologous bone marrow transplantation 0 0 0 0 0
Other 1 (2.0) 0 0 0 0
Prognosis at diagnosis: n (%)
<25% 1 (2.0) 0 0 0 0
25–75% 21 (42.9) 15 (36.6) 13 (31.7) 11 (26.2) 5 (18.5)
>75% 27 (55.1) 26 (63.4) 28 (68.3) 31 (73.8) 22 (81.5)*
Native country (the Netherlands): n (%) 48 (98.0) 41 (100) 40 (97.6) 41 (97.6) 26 (96.3)
*Survivors differed significantly from the survivors at M1, P < 0.05 (two-sided).
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M2 and M3 survivors tended to report better MCS than
at the first measurement occasion: b = 0.36, P = 0.06 and
b = 0.54, P = 0.08 respectively. Furthermore, a small
positive effect was found for vicarious control (b = 0.13,
P < 0.05). Good prognosis tended to be associated nega-
tively with MCS (b = -0.35, P = 0.07), as did interpretative
control (b = -0.13, P = 0.053).
Predictors of anxiety
Parameter estimates from the longitudinal mixed models
analyses of survivor’s level of anxiety are shown in
Table 3. Measurement occasion did not contribute signifi-
cantly to the model, where gender and coping were asso-
ciated significantly with anxiety. The female reported
higher levels of anxiety than the male (b = 0.60, P < 0.001),
which was a medium to large effect. Higher scores on
predictive control were associated with lower levels of
anxiety (b = -0.18, P < 0.05), but higher scores on inter-
pretative control were associated with higher levels of
anxiety (b = 0.18, P < 0.05). The effects of cognitive coping
were small to medium. Finally, survivors who were
treated with chemotherapy without radiotherapy tended
to report a higher level of anxiety (b = 0.51, P = 0.08) than
the other survivors.
DISCUSSION
Unlike cross-sectional studies, the present longitudinal
study on HRQoL, anxiety and disease-related coping of
school-aged survivors yielded insight into the process of
adjustment over time. The first few years of continuous
remission after the end of treatment were investigated, in
view of the importance of this phase in the run-up to
long-term survivorship. The results indicate that, in
general, school-aged survivors adjusted well to the cancer
experience. Compared with norm data from the general
Dutch population, survivors showed worse HRQoL only
with respect to Motor Functioning on average 2 months
after the end of treatment. From 1 year after treatment,
however, survivors did no longer differ from the norm
population. We should realize that – on purpose – the data
for patients who relapsed were excluded from analysis
from the moment of the relapse. Furthermore, survivors
having been treated for CNS cancer were not included in
the present study.
Our results were in line with the majority of studies
among long-term survivors of childhood cancer, in which
was found that their overall emotional adjustment as a
group was within normal limits (Stam et al. 2001). This is
not what would be expected considering the stressful
experience of childhood cancer and its treatment. It could
be partly attributable to the instruments we used. We
decided to use generic HRQoL instruments in order to be
able to compare the survivors with the general population.
The use of cancer-specific instruments, however, is rec-
ommended for measuring the impact of childhood cancer
longitudinally because this kind of instruments is more
sensitive to change. Unfortunately, cancer-specific instru-
ments translated and validated for Dutch school-aged chil-
dren are not available yet.
Another possible explanation could be ‘response shift’,
which has been described in adults with cancer (Sprangers
& Schwartz 1999). The experience with cancer can have
changed children’s conceptualization of problems, so that
fewer problems are being experienced. The good adjust-
ment could also be the result of adequate (family) coping
with the stresses of childhood cancer, as is discussed below.
It is important to identify factors that were associated
with HRQoL and anxiety so that survivors who are more
vulnerable to maladjustment can be traced. None of the
medical variables appeared to be associated significantly
Figure 1. Health-related quality of life (HRQoL) in survivors aged
8–11 and 12–15 years over measurement occasions: mean TNO-
AZL Children’s Quality of Life questionnaire (TACQOL) scale
scores† compared with the norm‡.
*Scale score differed significantly from the norm at P < 0.05 (two-
sided) at one sample t-test; **Scale score differed significantly
from the norm at P < 0.001 (two-sided) at one sample t-test.
†Higher scores represent better HRQoL: Range Motor and
Cognitive Functioning = 0–32, Range Positive and Negative
feelings = 0–16.
‡General Dutch population of children aged 8–11 years (Vogels
et al. 2004b) and 12–15 years (Vogels et al. 2004a).
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with HRQoL or anxiety. Female survivors, however,
reported higher levels of anxiety which is common in
the general population. Some correlations were found
between disease-related coping and the outcomes. First,
survivors who relied more strongly on the expertise of their
physician and attributed power to the cancer treatment
(vicarious control) reported better mental HRQoL (MCS). It
is well known that physicians play a role in diminishing
disease-related feelings of uncertainty. Second, survivors
who were more optimistic about the further course of the
disease (predictive control) experienced lower levels of
anxiety, while those who searched more for information
about the disease (interpretative control) reported higher
levels of anxiety. Causality can not be established but is
reasonable to assume that being more optimistic about the
further course of the disease can result in lower levels of
anxiety. The correlation between interpretative control
and anxiety is less clear. On one hand, survivors who feel
insecure and anxious may be more in need of information
about the disease. On the other hand, the gathered infor-
mation could reinforce anxiety.
Overall, the variables in the model explained only 13%,
9% and 21% of the variance for PCS, MCS and anxiety
respectively. The limited variance explained by the
medical variables is not surprising because these variables
were assessed rather roughly, and it was too short after
termination of treatment for the manifestation of late
effects of treatment. Besides, the limited impact of
medical variables on HRQoL has been found in many
studies among survivors of childhood cancer (Stam et al.
2001; Langeveld et al. 2002). Undoubtedly, there are other
psychosocial variables than the coping variables we
assessed in the present study that affect survivors’ HRQoL
and anxiety, for example, family functioning (Lesko 1990;
Rait et al. 1992; Kazak et al. 1997) and pre-cancer func-
tioning of the survivor.
Limitations and implications
The present study has several limitations that are common
in psychosocial research among children. Longitudinal
research on children is sparse because different age groups
Table 2. Parameter estimates for longitudinal regression models of health-related quality of life (HRQoL) (TNO-AZL Children’s Quality
of Life questionnaire) in survivors (aged 8–15 years) predicted by measurement occasion, demographic and medical characteristics and
disease-related cognitive coping
Fixed effects
Physical Component Scale
(TNO-AZL Children’s
Quality of Life questionnaire)
Mental Component Scale
(TNO-AZL Children’s
Quality of Life questionnaire)
Measurement (deviation from end of treatment; M1)
1 year (M2) 0.36*** 0.36*
2 years (M3) 0.32** 0.54*
3 years (M4) 0.33** 0.61
4 years (M5) 0.44*** 0.86
Percentage of explained variance by fixed effects 0.06 0.01
Medical and demographic characteristics†
Gender (female) – -0.32
Age – -0.22
Age at diagnosis – 0.34
Duration of treatment -0.10 –
Leukaemia or lymphoma (vs. solid tumours) – –
Radio- and chemotherapy – –
Chemotherapy without radiotherapy – –
Prognosis > 75% 0.16 -0.35*
Perceived treatment intensity – –
Visible consequences – –
Percentage of explained variance by fixed effects 0.10 0.07
Disease-related cognitive coping (Cognitive Control
Strategies Scale)
Predictive control 0.02 0.04
Interpretative control -0.10* -0.13*
Vicarious control 0.04 0.13**
Percentage of explained variance by fixed effects 0.13 0.09
Total number of observations 177 177
*P < 0.1; **P < 0.05; ***P < 0.01. The higher the score is the better the HRQoL. Dashes (–) mean that the variables were not included
in the model.
†Medical and demographic variables that were not correlated significantly at P < 0.3 with Physical Component Scale and/or Mental
Component Scale in the initial models were not selected for the final models.
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need different age-specific questionnaires resulting in
small sample size. Low power because of small sample size
could have contributed to the fact that few variables were
found to be predictive of HRQoL and anxiety. Furthermore,
because pre-selection of variables for the final analyses was
necessary, several medical variables were excluded in the
final models which could have led to underestimation of
the explained variance of the models. Another disadvan-
tage of the small sample size was that comparison of
survivors’ anxiety with that of the norm was not possible.
In addition, survivors of CNS cancer were not included
because these children are underrepresented in the longi-
tudinal VOLG study for logistical reasons.
Despite the small sample size at the last measurement
occasion, longitudinal analyses were possible because
linear mixed models analyses incorporate all available
data into analysis, including data from survivors that
missed one or more measurement occasion. Although
only 27 observations were available at M5, these observa-
tions could still be used to increase the precision of the
parameter estimates that are not specific to M5, such as
the fixed effects of coping. The attrition of survivors who
reached the age of 16 (because of the limited age range of
the TACQOL) did probably not bias the results seriously.
First, participants did not differ from the non-participants
at the several measurement occasions with respect to
their outcome scores at T1. Second, the impact of age and
medical variables on HRQoL and anxiety was limited in
the present study.
Another limitation concerns the outcomes of the study:
HRQoL and anxiety. Of course there are other interesting
aspects of survivors’ functioning, for instance posttrau-
matic stress, social functioning and educational achieve-
ment. It would be of utmost importance to investigate
indicators of social functioning because previous studies
revealed that school-aged survivors suffered from clini-
cally significant social anxiety, had less friends and par-
ticipated less in peer and school activities than controls
(Spirito et al. 1990; Pendley et al. 1997; Bessell 2001; Stam
et al. 2005). On the contrary, Reiter-Purtill et al. (2003)
concluded that 2 years after diagnosis survivors did not
exhibit more social difficulties than peers.
In conclusion, as a group survivors regained good
HRQoL after the end of successful cancer treatment in
the run-up to survivorship, no doubt, this is an important
finding that speaks well for the resilience of the survivors
and their parents. However, there is no reason to lean
back because of the known (long-term) late effects of
many treatments (Oeffinger et al. 2006; Geenen et al.
2007), whose relationship with survivors’ well-being is
not clear yet. Although there is little evidence of serious
maladjustment, research on more specific paediatric
psycho-oncology outcomes demonstrated that there is
consistently a group of children and family members
(estimated 25–30%) who do not cope well with the
cancer or who have personal, family and social difficul-
ties (Patenaude & Kupst 2005). The development of sen-
sitive cancer-related instruments is of utmost importance
to be used in psychosocial screening, as few clear medical
risk factors for worse psychosocial functioning could be
traced until now (Patenaude & Kupst 2005). It is satisfy-
ing that monitoring and screening survivors have become
standard aftercare in many hospitals in the last decade.
Apart from physical and psychosocial screening, the
Table 3. Parameter estimates for longitudinal regression models
of anxiety (State-Trait Inventory for Children) in survivors (aged
8–15 years) predicted by measurement occasion, demographic and
medical characteristics and disease-related cognitive coping
Fixed effects
Anxiety (State-Trait
Inventory for Children)
Measurement (deviation from end of
treatment; M1)
1 year (M2) -0.18
2 years (M3) -0.28
3 years (M4) -0.16
4 years (M5) -0.21
Percentage of explained variance by
fixed effects
0.004
Medical and demographic
characteristics†
Gender (female) 0.60***
Age 0.11
Age at diagnosis -0.23
Duration of treatment –
Leukaemia or lymphoma (vs. solid
tumours)
–
Radio- and chemotherapy –
Chemotherapy without
radiotherapy
0.51*
Prognosis > 75% –
Perceived treatment intensity –
Visible consequences -0.13
Percentage of explained variance by
fixed effects
0.12
Disease-related cognitive coping
(Cognitive Control Strategies
Scale)
Predictive control -0.18**
Interpretative control 0.18**
Vicarious control 0.00
Percentage of explained variance by
fixed effects
0.21
Total number of observations 190
*P < 0.1; **P < 0.05; ***P < 0.01. The higher the score is the
higher the level of anxiety. Dashes (–) mean that the variables
were not included in the model.
†Medical and demographic variables that were not correlated
significantly at P < 0.3 with anxiety in the initial models were
not selected for the final model.
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standard aftercare should preferably include education
and counselling directed at both survivors and their
parents. Providing psychosocial information on the
effects of the disease and treatment and assisting parents
in treating the survivors as normally as possible could
prevent late psychosocial problems by enhancing re-entry
into normal life.
Giving attention to the cognitive coping strategies of
the survivors might be useful when a survivor experiences
psychosocial problems. Although the longitudinal analy-
ses in the present study yielded stronger evidence of the
presence of causal correlations than do traditional analytic
procedures, they can not offer definitive proof of causality
between coping and outcomes. This requires an interven-
tion study intended to influence coping. There is evidence
of effectiveness for psycho-educational interventions for
children with a chronic disease incorporating cognitive-
behavioural techniques (Vannatta et al. 1998; Plante et al.
2001; Barlow & Ellard 2004; Last et al. 2007). Further steps
in the direction of evidence-based interventions for survi-
vors will be important in the years to come.
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